FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204977650> ?p ?o ?g. }

• W3204977650 endingPage "A545" @default.
• W3204977650 startingPage "A545" @default.
• W3204977650 abstract "TOPIC: Chest Infections TYPE: Original Investigations PURPOSE: Host T cell response plays a critical role in containment of M. tuberculosis (Mtb) infection by granuloma formation. The prevalence of multidrug-resistance tuberculosis (MDR-TB) among immunocompromised hosts (HIV co-infection & post-transplant patients) indicate the influence of host T cell response on MDR TB. Previously, we have shown critical role of regulatory T (Treg) cells and PD-1 pathway causing suppressed state of T cell response against Mycobacterium tuberculosis (Mtb) among TB patient. In this study, we attempted to understand the status of host immune response among the MDR and Drug Sensitive (DS) TB patients. We also checked the contribution of PD-1 pathway on poly-functional T cells (PFTs), critical for protective immunity in TB. METHODS: For immune response profile and in vitro experiments, polychromatic flowcytometry based immunological assays were performed. PD1 blocking experiments were performed in mice infected with Mtb and invitro model where monocyte derived macrophages (MDM) were infected with virulent Mtb DS strains. Furthermore, the impact of cytokine on the efflux pump of bacteria was evaluated using virulent Mtb DS strains infected MDM in presence of pro and anti-inflammatory cytokines. RESULTS: We observed marked reduction of polyfunctional T cells (PFTs) in TB patients. PFTs could be significantly rescued by blocking PD-1 pathway, which resulted in effective clearance of Mtb in MDM in vitro model. Blocking PD-1 pathway in mice infected with Mtb, demonstrated decrease in Tregs and restoration of PFTs with enhanced reduction of bacillary load in the lung & spleen relative to chemotherapy alone. Among MDR patients, we observed increase in the frequency of Tregs and decrease in frequency of Mtb specific T cell cytokine producers (IFN-γ or TNF-α or IFN-γ+ TNF-α+) compared to DS TB patients, suggesting a tight correlation of Treg mediated suppression with MDR status. Furthermore, we observed higher expression of efflux pump in DR strains which could be substantially modulated by pro-inflammatory (IFN-γ, TNF-α) and anti-inflammatory cytokines (IL10 and TGF β) in in vitro MDM model. Suppressive cytokines (IL10 and TGF β) increased the efflux pump of Mtb. This is suggestive of possible causal relation of host immune status with the drug efflux pump expression in Mtb. CONCLUSIONS: Our results demonstrate elicitation of weaker effector T cell response in DR TB compared to DS TB patients. Additionally, our findings suggest critical role of PD-1 in suppressing the protective immune response in TB. Rescuing PFTs by blocking PD-1 pathway may offer a novel strategy for adjunct immunotherapy in TB. This may be more relevant in MDR TB as PFT response may modulate the drug pump so as to increase the efficacy of chemotherapy. CLINICAL IMPLICATIONS: Rescuing appropriate immune response may improve the efficacy of anti-tubercular therapy in TB, especially for MDR TB with possible reduction of duration of drug therapy and relapse. DISCLOSURES: No relevant relationships by Sushmita Chakraborty, source=Web Response No relevant relationships by GOPIKA GUPTA, source=Web Response No relevant relationships by Divya Kamboj, source=Web Response no disclosure on file for Girija Mehta; No relevant relationships by Dipendra Mitra, source=Web Response No relevant relationships by Abhinav Saurabh, source=Web Response" @default.
• W3204977650 created "2021-10-25" @default.
• W3204977650 creator A5001178939 @default.
• W3204977650 creator A5026049181 @default.
• W3204977650 creator A5066407419 @default.
• W3204977650 creator A5081557405 @default.
• W3204977650 creator A5083839908 @default.
• W3204977650 creator A5091580994 @default.
• W3204977650 date "2021-10-01" @default.
• W3204977650 modified "2023-09-25" @default.
• W3204977650 title "INHIBITING PD-1 PATHWAY RESCUES PROTECTIVE IMMUNE RESPONSE IN TB PATIENTS: IMPACT ON BACILLARY EFFLUX PUMP AND MULTIDRUG-RESISTANCE TB" @default.
• W3204977650 doi "https://doi.org/10.1016/j.chest.2021.07.531" @default.
• W3204977650 hasPublicationYear "2021" @default.
• W3204977650 type Work @default.
• W3204977650 sameAs 3204977650 @default.
• W3204977650 citedByCount "0" @default.
• W3204977650 crossrefType "journal-article" @default.
• W3204977650 hasAuthorship W3204977650A5001178939 @default.
• W3204977650 hasAuthorship W3204977650A5026049181 @default.
• W3204977650 hasAuthorship W3204977650A5066407419 @default.
• W3204977650 hasAuthorship W3204977650A5081557405 @default.
• W3204977650 hasAuthorship W3204977650A5083839908 @default.
• W3204977650 hasAuthorship W3204977650A5091580994 @default.
• W3204977650 hasBestOaLocation W32049776501 @default.
• W3204977650 hasConcept C114851261 @default.
• W3204977650 hasConcept C133936738 @default.
• W3204977650 hasConcept C142724271 @default.
• W3204977650 hasConcept C159047783 @default.
• W3204977650 hasConcept C200082930 @default.
• W3204977650 hasConcept C203014093 @default.
• W3204977650 hasConcept C2777975735 @default.
• W3204977650 hasConcept C2781069245 @default.
• W3204977650 hasConcept C54355233 @default.
• W3204977650 hasConcept C71924100 @default.
• W3204977650 hasConcept C86803240 @default.
• W3204977650 hasConcept C8891405 @default.
• W3204977650 hasConcept C89423630 @default.
• W3204977650 hasConceptScore W3204977650C114851261 @default.
• W3204977650 hasConceptScore W3204977650C133936738 @default.
• W3204977650 hasConceptScore W3204977650C142724271 @default.
• W3204977650 hasConceptScore W3204977650C159047783 @default.
• W3204977650 hasConceptScore W3204977650C200082930 @default.
• W3204977650 hasConceptScore W3204977650C203014093 @default.
• W3204977650 hasConceptScore W3204977650C2777975735 @default.
• W3204977650 hasConceptScore W3204977650C2781069245 @default.
• W3204977650 hasConceptScore W3204977650C54355233 @default.
• W3204977650 hasConceptScore W3204977650C71924100 @default.
• W3204977650 hasConceptScore W3204977650C86803240 @default.
• W3204977650 hasConceptScore W3204977650C8891405 @default.
• W3204977650 hasConceptScore W3204977650C89423630 @default.
• W3204977650 hasIssue "4" @default.
• W3204977650 hasLocation W32049776501 @default.
• W3204977650 hasOpenAccess W3204977650 @default.
• W3204977650 hasPrimaryLocation W32049776501 @default.
• W3204977650 hasRelatedWork W2031842446 @default.
• W3204977650 hasRelatedWork W2064133695 @default.
• W3204977650 hasRelatedWork W2067784550 @default.
• W3204977650 hasRelatedWork W2119435924 @default.
• W3204977650 hasRelatedWork W2133257688 @default.
• W3204977650 hasRelatedWork W2162580901 @default.
• W3204977650 hasRelatedWork W2361644957 @default.
• W3204977650 hasRelatedWork W2947818689 @default.
• W3204977650 hasRelatedWork W4310811299 @default.
• W3204977650 hasRelatedWork W2747188662 @default.
• W3204977650 hasVolume "160" @default.
• W3204977650 isParatext "false" @default.
• W3204977650 isRetracted "false" @default.
• W3204977650 magId "3204977650" @default.
• W3204977650 workType "article" @default.